We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 275

The Weekly Hill Update
  • Baker & Hostetler LLP
  • USA
  • June 11 2018

Below is the Federal Policy team’s weekly preview published each Monday that Congress is in session


Trump’s 2-for-1 Executive Order, its Impact on FDA, and the Significance of “Significant”
  • Arent Fox LLP
  • USA
  • February 10 2017

On the heels of a January 20, 2017 memorandum freezing the release of any new or pending regulations until they have been reviewed and approved by


Roy G. Zou
  • Hogan Lovells

Robert J. Anello
  • Morvillo Abramowitz Grand Iason & Anello PC

Natasha Eckard Hammond
  • Squire Patton Boggs

Kathleen P. Rubinstein
  • Baker & Hostetler LLP

Dana Weekes
  • Arnold & Porter Kaye Scholer LLP

Lindsay B. Meyer
  • Venable LLP

Chelsea Deppert
  • Fisher Phillips

Shannon Britton Hartsfield
  • Holland & Knight LLP